Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products

NCT02976753 · clinicaltrials.gov ↗

COMPLETED

Status

361

Enrollment

INDUSTRY

Sponsor class

Conditions

Hemophilia A

Interventions

DRUG: efmoroctocog alfa
DRUG: Factor VIII

Sponsor

Swedish Orphan Biovitrum

Collaborators

[object Object]